Michael Jerman

Michael Jerman

Director/Board Member at HEDGEPATH PHARMACEUTICALS INC

Net worth: 51 274 $ as of 2026-05-30

42 year
Health Technology
Consumer Services
Commercial Services

Profile

Mr. Michael A. Jerman is an Independent Director at Alaunos Therapeutics, Inc., an Independent Director at Inhibitor Therapeutics, Inc. and a Managing Partner at Hollywell Partners LLC.
He is on the Board of Directors at Alaunos Therapeutics, Inc. and Inhibitor Therapeutics, Inc. Mr. Jerman was previously employed as an Independent Director by MIRA Pharmaceuticals, Inc. and an Independent Director by Telomir Pharmaceuticals, Inc. He also served on the board at PricewaterhouseCoopers LLP.
He received his undergraduate degree from the University of South Florida, a graduate degree from The University of Tampa, Inc. and an MBA from the University of Oxford.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-28 15,621 ( 0.64% ) 44 520 $ 2026-05-30
2025-03-31 80,411 ( 0.05% ) 6 755 $ 2026-05-30

Michael Jerman active positions

CompaniesPositionStart
HEDGEPATH PHARMACEUTICALS INC Director/Board Member 2023-05-23
ALAUNOS THERAPEUTICS, INC. Director/Board Member 2025-07-14
Corporate Officer/Principal 2019-04-30

Former positions of Michael Jerman

CompaniesPositionEnd
TELOMIR PHARMACEUTICALS, INC. Director/Board Member 2024-11-17
MIRA PHARMACEUTICALS, INC. Director/Board Member 2024-11-17
Director/Board Member 2019-07-31
See the detail of Michael Jerman's experience

Training of Michael Jerman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Jerman
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!